The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Exhibit Hall Presentation <br>Janssen invites you to learn more about a treatment option for patients diagnosed with Multiple Myeloma who are Relapsed/Refractory and have received >=4 prior lines of therapy</br>Janssen Oncology part of the Pharmaceutical Companies of Johnson & Johnson</br>